Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Requena

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Actas Urologicas Espanolas|July 24, 1998
[Retrovesical hydatic cyst]E C Carmona Campos, J C Regueiro López, J Alvarez Kindelán, et al.
American Journal of Hematology|February 28, 2003
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, M J Requena, P Martín-Regueira, et al.
Actas Urologicas Espanolas|May 7, 2003
[Association of renal carcinoma and the exposure to ionizing radiation after the Chernobyl accident]A Blanco Espinosa, M Leva Vallejo, F Merlo de la Peña, et al.
Nuclear Medicine Communications|October 1, 1989
99Tcm-MAG3 for quantitation of differential renal functionJ M Llamas-Elvira, M Martinez-Paredes, A Jimenez-Heffernan, et al.
Transfusion|April 1, 1997
The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, I Pinilla, M J Requena, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
American Journal of Hematology|November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)J L Steegmann, M J Requena, L F Casado, et al.
Actas Urologicas Espanolas|March 1, 1997
[Management of obstructive renal candidiasis. Report of a clinical case]J Alvarez Kindelán, V Alameda Aragonéses, J C Regueiro López, et al.
BJU International|March 27, 2003
Combined treatment with vitamin E and colchicine in the early stages of Peyronie's diseaseR M Prieto Castro, M E Leva Vallejo, J C Regueiro Lopez, et al.
The Journal of Pathology|May 3, 2008
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urotheliumA Lopez-Beltran, J Alvarez-Kindelan, R J Luque, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Actas Urologicas Espanolas|July 24, 1998
[Retrovesical hydatic cyst]E C Carmona Campos, J C Regueiro López, J Alvarez Kindelán, et al.
American Journal of Hematology|February 28, 2003
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, M J Requena, P Martín-Regueira, et al.
Actas Urologicas Espanolas|May 7, 2003
[Association of renal carcinoma and the exposure to ionizing radiation after the Chernobyl accident]A Blanco Espinosa, M Leva Vallejo, F Merlo de la Peña, et al.
Nuclear Medicine Communications|October 1, 1989
99Tcm-MAG3 for quantitation of differential renal functionJ M Llamas-Elvira, M Martinez-Paredes, A Jimenez-Heffernan, et al.
Transfusion|April 1, 1997
The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-alphaJ L Steegmann, I Pinilla, M J Requena, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
American Journal of Hematology|November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)J L Steegmann, M J Requena, L F Casado, et al.
Actas Urologicas Espanolas|March 1, 1997
[Management of obstructive renal candidiasis. Report of a clinical case]J Alvarez Kindelán, V Alameda Aragonéses, J C Regueiro López, et al.
BJU International|March 27, 2003
Combined treatment with vitamin E and colchicine in the early stages of Peyronie's diseaseR M Prieto Castro, M E Leva Vallejo, J C Regueiro Lopez, et al.
The Journal of Pathology|May 3, 2008
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urotheliumA Lopez-Beltran, J Alvarez-Kindelan, R J Luque, et al.
Pageof 16